The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 3.44 — safe zoneOK
- Earnings-manipulation signal · Beneish M -2.91 — no flag raisedOK
- Earnings quality 95/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as AtriCure, Inc. reports it. History and quarterly detail are in the app.
- Appendage management$220.2M
- Open ablation$184.9M
- Pain management$89.6M
- Minimally invasive ablation$39.8M
- Shipping and Handling$2.5M
Leadership changes
From AtriCure, Inc.'s own filings, the day they're filed.
- Biosense Webster · director · appointment
Latest filings
- 8-K · Company announcement2026-05-19
- 10-Q · Quarterly report2026-05-06
- 8-K · Company announcement2026-05-05
- DEF 14A · Annual proxy (pay & governance)2026-04-06
- 10-K · Annual report2026-02-19
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about AtriCure, Inc., every answer cited🔒
- The Intelligence Brief — added when AtriCure, Inc.'s brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.